MarketCap
Facebook
X
TelegramQuartalsbericht 2022-Q3
hinzugefügt 15.12.2022
OncoSec Medical Incorporated ROCE 2011-2026 | ONCS
ROCE Jährlich OncoSec Medical Incorporated
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -604.93 | -127.06 | -214.63 | -122.08 | -147.99 | -181.2 | -92.9 | -64.97 | -31.39 | -149.08 | -102.25 | 196.04 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 196.04 | -604.93 | -136.87 |
ROCE Vierteljährlich OncoSec Medical Incorporated
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 557.22 | 581.84 | -126.1 | -189.31 | -156.83 | -559.88 | -605.76 | -686.55 | -730.63 | -339.06 | -323.04 | -283.54 | -267.52 | -279.1 | -244.55 | -202.05 | -167.5 | -149.12 | -163.12 | -156.26 | -181.9 | -178.95 | -159.07 | -127.31 | -94.18 | -84.37 | -86.32 | -83.04 | -79.06 | -78.04 | -63.92 | -53.12 | -46.53 | -52.7 | -54.05 | -81.89 | -83.25 | -5.44 | -66.75 | -83.25 | -115.29 | -378.78 | -510.0 | -456.07 | -154.83 | -205.61 | 0.29 | 50.5 |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 581.84 | -730.63 | -166.75 |
ROCE anderer Aktien in der Pharmaeinzelhändler
| Name | ROCE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
2.89 | - | 2.43 % | $ 254 M |  Germany |
 |
AgeX Therapeutics
AGE
|
64924.32 | - | -10.17 % | $ 12.2 K |  USA |
 |
Midatech Pharma plc
MTP
|
-337.43 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Esperion Therapeutics
ESPR
|
-19.96 | $ 3.13 | 0.55 % | $ 651 M | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
17.36 | - | - | $ 40.3 B | USA |
 |
Exelixis
EXEL
|
40.35 | $ 46.48 | 4.64 % | $ 12.6 B | USA |
 |
Fortress Biotech
FBIO
|
-140.8 | $ 2.5 | 1.63 % | $ 69.8 M | USA |
 |
Biophytis SA
BPTS
|
-325.06 | - | -13.47 % | $ 169 M |  France |
 |
Genfit SA
GNFT
|
-49.48 | - | 2.54 % | $ 160 B | France |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-61.36 | - | -1.52 % | $ 24.7 M | USA |
 |
Athira Pharma
ATHA
|
-368.0 | - | - | $ 269 M | USA |
 |
Galapagos NV
GLPG
|
-3.51 | $ 28.79 | 1.41 % | $ 2.69 B |  Belgium |
 |
Genmab A/S
GMAB
|
31.74 | $ 27.79 | 0.92 % | $ 17.1 B |  Danmark |
 |
Genprex
GNPX
|
-194.87 | $ 0.9 | 1.12 % | $ 839 K | USA |
 |
Grifols, S.A.
GRFS
|
7.15 | $ 8.33 | 0.73 % | $ 6.83 B |  Spain |
 |
InflaRx N.V.
IFRX
|
-24.77 | $ 2.51 | 27.51 % | $ 152 M | Germany |
 |
Immuron Limited
IMRN
|
-12.29 | $ 0.8 | 1.39 % | $ 6.7 M |  Australia |
 |
Ionis Pharmaceuticals
IONS
|
-43.85 | $ 76.27 | 1.36 % | $ 12.2 B | USA |
 |
BioNTech SE
BNTX
|
-4.81 | $ 95.08 | -0.44 % | $ 27.2 B | Germany |
 |
Институт стволовых клеток человека
ISKJ
|
15.18 | - | - | - |  Russia |
 |
Kamada Ltd.
KMDA
|
10.36 | $ 8.28 | 0.85 % | $ 260 M |  Israel |
 |
Checkmate Pharmaceuticals
CMPI
|
-88.5 | - | - | $ 231 M | USA |
 |
Kymera Therapeutics
KYMR
|
-22.12 | $ 85.67 | 3.58 % | $ 7.24 B | USA |
 |
Kazia Therapeutics Limited
KZIA
|
-45.76 | $ 13.28 | -1.26 % | $ 1.76 B | Australia |
 |
INmune Bio
INMB
|
-201.42 | $ 1.54 | - | $ 38.1 M | USA |
 |
Ligand Pharmaceuticals Incorporated
LGND
|
-2.72 | $ 232.25 | -0.02 % | $ 4.25 B | USA |
 |
Liquidia Corporation
LQDA
|
-114.81 | $ 41.83 | 4.24 % | $ 3.6 B | USA |
 |
ACADIA Pharmaceuticals
ACAD
|
31.5 | $ 22.89 | 2.42 % | $ 3.79 B | USA |
 |
Mirum Pharmaceuticals
MIRM
|
-7.03 | $ 108.2 | 2.26 % | $ 5.43 B | USA |
 |
Advaxis
ADXS
|
429.74 | - | -9.65 % | $ 45.9 M | USA |
 |
MannKind Corporation
MNKD
|
-76.05 | $ 3.84 | 34.27 % | $ 1.17 B | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-146.69 | $ 3.51 | 0.29 % | $ 5.78 M | Israel |
 |
Aeterna Zentaris
AEZS
|
-29.95 | - | 5.93 % | $ 314 M |  Canada |
 |
Aeglea BioTherapeutics
AGLE
|
-29.3 | - | - | $ 1.01 B | USA |
 |
CureVac N.V.
CVAC
|
-51.5 | - | - | $ 867 M | Germany |
 |
Applied Genetic Technologies Corporation
AGTC
|
-60.13 | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
-80.33 | - | 1.93 % | $ 17.4 M | USA |
 |
Akero Therapeutics
AKRO
|
-38.05 | - | - | $ 3.67 B | USA |
 |
Aptose Biosciences
APTO
|
-46.69 | - | -45.71 % | $ 1.2 M | Canada |
 |
Aptinyx
APTX
|
-163.42 | - | -39.0 % | $ 4.57 M | USA |
 |
Akouos
AKUS
|
-37.16 | - | 0.23 % | $ 488 M | USA |
 |
Albireo Pharma
ALBO
|
-70.32 | - | -0.23 % | $ 916 M | USA |
 |
Allakos
ALLK
|
-116.14 | - | - | $ 28.6 M | USA |
 |
AlloVir
ALVR
|
-58.56 | - | 4.14 % | $ 49.1 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
-6.45 | $ 23.68 | 1.09 % | $ 3.01 B | USA |
 |
Nanobiotix S.A.
NBTX
|
-31.68 | $ 41.17 | 18.39 % | $ 286 B | France |
 |
Allena Pharmaceuticals
ALNA
|
-252.54 | - | 3.16 % | $ 1.9 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
-75.24 | - | -11.43 % | $ 502 K | USA |
 |
Applied Molecular Transport
AMTI
|
-209.11 | - | - | $ 10.1 M | USA |